Transnuclear TRP1-Specific CD8 T Cells with High or Low Affinity TCRs Show Equivalent Antitumor Activity

Transnuclear TRP1-Specific CD8 T Cells with High or Low Affinity TCRs Show Equivalent Antitumor Activity

We have generated, via somatic cell nuclear transfer, two independent lines of transnuclear (TN) mice, using as nuclear donors CD8 T cells, sorted by tetramer staining, that recognize the endogenous melanoma antigen TRP1. These two lines of nominally identical specificity differ greatly in their aff...

Full description

Bibliographic Details
Main Authors:	Dougan, S. K., Dougan, M., Turner, J. A., Ogata, S., Cho, H.-I., Jaenisch, R., Celis, E., Ploegh, H. L., Kim, Jun
Other Authors:	Massachusetts Institute of Technology. Department of Biology
Format:	Article
Published:	American Association for Cancer Research (AACR) 2018
Online Access:	http://hdl.handle.net/1721.1/116615

Similar Items

Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden
by: Sanecka, Anna, et al.
Published: (2019)

Transnuclear Mice with Pre-defined T Cell Receptor Specificities Against Toxoplasma gondii Obtained via SCNT
by: Suh, Heikyung, et al.
Published: (2013)

Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cells
by: Avalos, Ana M., et al.
Published: (2014)

Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.
by: Trautmann, L, et al.
Published: (2005)

CD8+ T Cells from Mice Transnuclear for a TCR that Recognizes a Single H-2Kb-Restricted MHV68 Epitope Derived from gB-ORF8 Help Control Infection
by: Sharvan Sehrawat, et al.
Published: (2012-05-01)

CD8[superscript +] T Cells from Mice Transnuclear for a TCR that Recognizes a Single H-2K[superscript b]-Restricted MHV68 Epitope Derived from gB-ORF8 Help Control Infection
by: Sehrawat, Sharvan, et al.
Published: (2014)

394 High-affinity PRAME TCRs synergize with tailored CD8 co-receptor and switch receptors to generate potential best-in-class PRAME-targeting TCR-T therapy
by: Elisa Kieback, et al.
Published: (2023-11-01)

Durable antitumor responses to CD47 blockade require adaptive immune stimulation
by: Sockolosky, Jonathan T., et al.
Published: (2016)

PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
by: Rosa A. van Amerongen, et al.
Published: (2023-03-01)

Public T-Cell Receptors (TCRs) Revisited by Analysis of the Magnitude of Identical and Highly-Similar TCRs in Virus-Specific T-Cell Repertoires of Healthy Individuals
by: Wesley Huisman, et al.
Published: (2022-03-01)

Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs
by: Sofya A Kasatskaya, et al.
Published: (2020-12-01)

Structural basis for self-discrimination by neoantigen-specific TCRs
by: John P. Finnigan, et al.
Published: (2024-03-01)

WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma
by: Peter A van Veelen, et al.
Published: (2022-06-01)

Adoptive Immunotherapy Based on Chain-Centric TCRs in Treatment of Infectious Diseases
by: Anastasiia A. Kalinina, et al.
Published: (2020-12-01)

Strategies to improve γδTCRs engineered T-cell therapies for the treatment of solid malignancies
by: A. D. Meringa, et al.
Published: (2023-06-01)

The Hypervariable Loops of Free TCRs Sample Multiple Distinct Metastable Conformations in Solution
by: James E. Crooks, et al.
Published: (2018-11-01)

Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
by: Melanie Boxberg, et al.
Published: (2021-09-01)

Comparison of T cell activities mediated by human TCRs and CARs that use the same recognition domains
by: Harris, DT, et al.
Published: (2017)

Landscape mapping of shared antigenic epitopes and their cognate TCRs of tumor-infiltrating T lymphocytes in melanoma
by: Kenji Murata, et al.
Published: (2020-04-01)

Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
by: Pierre Dillard, et al.
Published: (2021-01-01)

An Ig transmembrane domain motif improves the function of TCRs transduced in human T cells: Implications for immunotherapy
by: D'Apice, L, et al.
Published: (2019)

Antitumor response to microscopic melanoma in the gastric mucosa mimicking ipilimumab-induced gastritis
by: Elisa Bello, et al.
Published: (2019-02-01)

Heterodimeric Fc-fused IL12 shows potent antitumor activity by generating memory CD8+ T cells
by: Keunok Jung, et al.
Published: (2018-07-01)

Transgenic Mice Expressing Functional TCRs Specific to Cardiac Myhc-α 334–352 on Both CD4 and CD8 T Cells Are Resistant to the Development of Myocarditis on C57BL/6 Genetic Background
by: Meghna Sur, et al.
Published: (2023-09-01)

Affine-periodic solutions by asymptotic and homotopy equivalence
by: Jiamin Xing, et al.
Published: (2020-04-01)

An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies
by: Lei Chen, et al.
Published: (2021-09-01)

CD137 Agonists Targeting CD137-Mediated Negative Regulation Show Enhanced Antitumor Efficacy in Lung Cancer
by: Ling Yi, et al.
Published: (2022-02-01)

Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity
by: Deyong Song, et al.
Published: (2021-11-01)

Natural Self-Ligand Gamma Delta T Cell Receptors (γδTCRs) Insight: The Potential of Induced IgG
by: Thamires Rodrigues de Sousa, et al.
Published: (2020-08-01)

TRP channels /
by: Zhu, Michael X. 524478
Published: (2011)

(In)equivalence of metric-affine and metric effective field theories
by: Gianfranco Pradisi, et al.
Published: (2022-09-01)

A Method for Determining the Affine Equivalence of Boolean Functions
by: Ziyu Wang, et al.
Published: (2019-01-01)

One-dimensional diffusion of TrpR along DNA enhances its affinity for the operator by chemical ratchet mechanism
by: Takashi Kinebuchi, et al.
Published: (2021-02-01)

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells
by: Rosmely Hernandez, et al.
Published: (2023-06-01)

Deciphering Repertoire of B16 Melanoma Reactive TCRs by Immunization, In Vitro Restimulation and Sequencing of IFNγ-Secreting T Cells
by: Anna V. Izosimova, et al.
Published: (2021-09-01)

Rapid identification of CMV-specific TCRs via reverse TCR cloning system based on bulk TCR repertoire data
by: Cheol-Hwa Hong, et al.
Published: (2022-11-01)

Massively Parallel Microfluidic Cell-Pairing Platform for the Statistical Study of Immunological Cell-Cell Interactions
by: Hoehl, Melanie Margarete, et al.
Published: (2013)

Novel tetramer technology for the detection of high affinity CD8 T cells
by: Hoffmann, M, et al.
Published: (2009)

An Anti-CD7 Antibody–Drug Conjugate Target Showing Potent Antitumor Activity for T-Lymphoblastic Leukemia (T-ALL)
by: Shiqi Wang, et al.
Published: (2024-01-01)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
by: Shahram Salek-Ardakani, et al.
Published: (2021-10-01)